Study Summary
This trial is testing a new device that could help people with arm weakness or paralysis to improve arm function.
Eligible Conditions
- Neurological Disorders
- Spastic Weakness
- Spinal Muscular Atrophy
- Arm Paralysis
- Charcot-Marie-Tooth Disease
- Cerebral Palsy
- ALS (Amyotrophic Lateral Sclerosis)
- Weakness of Extremities After Stroke
- Hemiparesis
- Arthrogryposis
- Stroke
- Quadriplegia
- Spinal Cord Injury
- Muscular Dystrophy
Treatment Effectiveness
Phase-Based Effectiveness
N/A
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: 8 weeks
8 Weeks
Upper arm
8 weeks
Change from Baseline Motricity Index score at 8 weeks
Change in ABILHAND-Kids questionnaire score at 8 weeks (for participants aged < 18)
Change in Box and Blocks score at 8 weeks
Change in Canadian Occupational Performance Measure score at 8 weeks
Trial Safety
Phase-Based Safety
Awards & Highlights
No Placebo Group
All patients enrolled in this trial will receive the new treatment.
Trial Design
1 Treatment Group
Treatment Arm
1 of 1
Experimental Treatment
20 Total Participants · 1 Treatment Group
Primary Treatment: Neurosleeve · No Placebo Group · N/A
Treatment Arm
Device
Experimental Group · 1 Intervention: Neurosleeve · Intervention Types: DeviceTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 8 weeks
Who is running the clinical trial?
Thomas Jefferson UniversityLead Sponsor
416 Previous Clinical Trials
136,794 Total Patients Enrolled
Eligibility Criteria
Age Any Age · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You have weakness caused by a long-term neurological or orthopedic condition/injury that happened at least 6 months ago.
You do not have any problems that limit the movement of your affected leg(s) and prevent you from using a wearable, powered orthotic device on your arm.